A carregar...
αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors
The α9-containing nicotinic acetylcholine receptor (nAChR) is increasingly emerging as a new tumor target owing to its high expression specificity in breast cancer. αO-Conotoxin GeXIVA is a potent antagonist of α9α10 nAChR. Nevertheless, the anti-tumor effect of GeXIVA on breast cancer cells remains...
Na minha lista:
| Publicado no: | Mar Drugs |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7231225/ https://ncbi.nlm.nih.gov/pubmed/32272701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md18040195 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|